Salvage Therapies for Radiorecurrent Prostate Cancer Offer Similar RFS
Investigators found no significant differences in 5-year RFS rates between RP and the other salvage modalities.
Investigators found no significant differences in 5-year RFS rates between RP and the other salvage modalities.
Delaying radical prostatectomy for high-risk clinically localized prostate cancer for up to 6 months does not increase the risk for adverse pathologic outcomes, a study found.
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
Deferring radical prostatectomy for intermediate- and high-risk prostate cancer for several months does not increase the risk for adverse oncologic findings.
Functional and oncologic outcomes, autonomous decision-making, and follow-up time influence regret.
A retrospective chart review demonstrated that pelvic floor muscle training can help relieve prostatectomy-related incontinence and pain in men with prostate cancer.
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies.
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
The risk of virtually all early postoperative complications increases with increasing patient age at radical prostatectomy for localized prostate cancer.